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Cadmium is one of the heavy metals, it is often used in industry, and exerts toxic 
effects on human health. Cadmium is classified as a carcinogenic substance for humans 
by the International Agency for Research on Cancer and is in a group I carcinogen. 
Cadmium affects the development of cell cycle, proliferation, differentiation, DNA repair, 
replication and apoptosis, as well as promotion of cancer in tissues. Intoxication with 
cadmium in people usually occurs by inhalation of cigarette smoke, but it is also possible 
via water, food and air. Cadmium exerts toxic effects on the kidneys, liver, lungs, 
cardiovascular system, immune system and reproductive system. Metallothionein 
protects tissues from the toxicity of cadmium. Cadmium-metallothionein complex is 
distributed in various tissues. There is no way for natural cadmium elimination from the 
human body. The main route of cadmium in the body is through binding with 
metallothionein, low molecular weight protein that participates in the homeostasis of 
certain metals. Cadmium-metallothionein complex is distributed in various tissues. The 
role of metallothionein in detoxification of cadmium is primarily in the large binding 
affinity of metals for metallothionein. Acta Medica Medianae 2012;51(4):65-70. 
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Introduction 
 
  Cadmium was discovered as an element in 
1817, but its application was negligible until the last 
f i f t y  y e a r s .  I t  i s  u s e d  i n  t h e  p r o d u c t i o n  o f  N i - C d  
batteries, ceramics, paints, textiles and plastics. It 
enters the environment from mining and smelting 
processes of zinc and lead. Cadmium is absorbed 
through the respiratory tract by up to 30% from the 
environment. A significant route of the introduction of 
cadmium is through cigarette smoke, as one cigarette 
contains 1-2mg of cadmium. Smokers have 4–5 times 
higher blood cadmium concentrations than non-
smokers. 
  Gastrointestinal absorption of cadmium is up to 
8%, and by inhalation up to 30%. Absorption, 
however, increases if one takes the food which has a 
reduced content of calcium, iron and protein. Zinc 
reduces the absorption of cadmium probably by 
stimulating the synthesis of metallothionein. Cadmium 
is transported via blood, bound to erythrocytes and 
large masses of proteins such as albumin, although a 
small portion can be transferred to metallothionein. 
Approximately 50-75% of the total content of 
cadmium in the body is located in the liver and 
kidneys. It is not exactly known how long the 
cadmium retains in the body, but it is assumed that 
its half-life can be 10-30 years (1). 
  In 2005, the production of cadmium was about 
17.800 tons. However, the use of cadmium in the 
developed countries has begun to decline because of 
its toxicity. 
  Cadmium intoxication in humans usually occurs 
by inhaling the cigarette smoke; however, it is also 
possible through water, food and air. During acute 
intoxication, damages to liver, lung and testis have 
been reported (2,3). During chronic intoxication, 
obstructive pulmonary disease, disturbed metabolism, 
regulation of blood pressure, kidney function, 
structure of bones and immune system occur (4-6). 
 
  Acute cadmium poisoning 
  
  Acute toxic effects may be caused by taking 
large doses of cadmium through contaminated food or 
drink and smoke inhalation. As symptoms of acute 
poisoning, nausea, vomiting and abdominal pain have 
been cited. Inhalation of smoke with increased 
content of cadmium can cause acute pneumonitis and 
pulmonary edema, which can result in fatal outcome 
(1). 
 
  Chronic cadmium poisoning 
 
  Effects of long-term exposure in small concen-
trations of cadmium are chronic obstructive pulmo-
nary disease, emphysema, osteoporosis, hyper-
tension, chronic renal tubular damage and lungs, 
kidneys and pancreas cancer. The effects on the 
respiratory system are proportional to the time and 
level of exposure, with pronounced symptoms of 
chronic bronchitis, progressive fibrosis, lower 
respiratory tract and damage to the alveoli (1). Toxic effects of cadmium                                                                                                                                  Tanja Vukićević 
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  Effects of cadmium on cell 
 
  Cadmium affects the development of cell cycle, 
proliferation, differentiation, DNA repair, replication, 
and apoptosis. Intracellular activated signals inhibit 
the DNA methylation and/or interfere with E-cadherin 
that affects the cell adhesion. Cadmium in 
concentrations higher than 1μM inhibits the DNA 
synthesis and to a lesser concentration stimulates the 
DNA synthesis and cell proliferation (7,8). These 
effects are dose-dependent. 
 
  Biomarkers of cadmium detection 
 
  The main route of cadmium in the body is 
binding to metallothionein (MT), the low molecular 
weight protein that participates in the homeostasis of 
some metals. Cadmium-metallothionein complex is 
distributed in various tissues. Human body does not 
have a mechanism for cadmium elimination. Urinary 
excretion of cadmium is proportional to body mass. A 
recent exposure to cadmium is estimated on the basis 
of its level in the blood. A few months after the 
exposure, the levels of cadmium decreases, but 
remain at a higher level than that which existed 
previously (9). 
 
  Carcinogenic effects of cadmium 
 
  Cadmium compounds are potential carcino-
gens. Compounds such as cadmium chloride, oxide, 
sulfate, and sulfide produce sarcomas in rats after 
subcutaneous and intramuscular administration. The 
effect is dose-dependent because higher doses of 
cadmium caused much more aggressive sarcomas 
that show a greater effect of local invasion and 
metastasis (10). 
  Cadmium also induces the appearance of 
testicular tumors, especially benign tumor cells, but 
this is usually associated with high doses that lead to 
testicular necrosis, testicular atrophy, and excessive 
secretion of luteinizing hormone. Other studies have 
shown that exposure to cadmium can induce tumors 
of the pancreas, adrenal glands, liver, kidney, thyroid 
gland, and hematopoietic system in mice, rats and 
hamsters. Cadmium may be carcinogenic after 
inhalation, oral and parenteral administration (10). 
  Cadmium was classified as a carcinogenic 
substance to humans by IARC (International Agency 
for Research on Cancer) in 1997 and belongs to the 
group I carcinogen. 
  The development of lung cancer in experi-
mental animals is associated with inhalation of 
cadmium (11). 
  The mechanism by which cadmium affects the 
process of carcinogenesis is not known. It probably 
increases cell proliferation and apoptosis by DNA 
damage (11). 
 
  Toxicokinetics 
 
  Cadmium is transported in the blood by 
albumin and has high molecular weight. It is rapidly 
distributed in tissues and deposited in the liver and 
kidneys. In the liver, kidneys and other tissues, 
cadmium induces the formation of metallothionein 
(12). 
  Cadmium is deposited in the liver as a complex 
of cadmium-metallothionein (Cd-MT). Cadmium-
metallothionein complex may be released from the 
liver and transported via blood to the kidneys where it 
is reabsorbed and broken down into lysosomes of 
renal tubules. This release of cadmium induces the 
creation of Cd-MT complexes or cause renal toxicity. 
When it comes to saturation in developing links with 
free metallothionein and when there is no possibility 
of removing free cadmium, tubular damage may 
occur (13). 
  Cadmium can pass through the placenta. The 
placenta is permeable to all substances with a 
molecular weight less than 1000 Dalton. Thus the 
placenta does not prevent the passage of toxins from 
mother to fetus, and therefore nicotine and toxins 
from tobacco smoke, including cadmium and a large 
number of drugs, can pass into the fetus. Cadmium 
was found to cause toxic effects on the level of the 
placenta by reducing the transport of zinc through the 
placenta causing zinc deficiency in the fetus (1). 
 
  Nephrotoxicity 
 
  Cadmium is toxic to the tubules and 
glomerulus. It significantly impairs the renal function. 
The lesions consist of initial necrosis of tubular cell 
degeneration in excess of interstitial inflammation and 
fibrosis. There seems to be detached critical 
concentration of cadmium in the renal cortex, which 
causes tubular dysfunction (18). 
  Cadmium damages the kidney proximal tubule. 
It is believed that glomerular lesion is predominant in 
the initial stage of cadmium exposure. It causes 
damage to tubular reabsorption, with consequent 
proteinuria, glycosuria, phosphaturia. The first sign of 
damage is increased excretion of low molecular 
weight proteins (tubular proteinuria). Disruption of 
renal regulation of calcium and phosphorus can cause 
resorption of these minerals from the bones 
(occurrence of osteomalacia and kidney stones are 
described). Cadmium-induced renal toxicity is 
characterized by proteinuria. Prevalent protein: β2-
microglobulin, N-acetyl-β-D-glucosaminidase and 
metallothionein, and retinol binding proteins, 
lysosomal enzymes, ribonuclease, α1-microglobulin 
and immunoglobulins short chains (13,14). The 
presence of larger proteins such as albumin and 
transferrin in urine after exposure to cadmium are 
indicative of glomerulus damage (13). Urinary 
excretion of protein and cadmium is used as a 
biomarker of cadmium exposure. 
  Damage to the renal blood vessels occurs most 
frequently in the last stage of disease. It is necessary 
to introduce biomarkers that can provide early 
detection of blood cells that are damaged by 
cadmium. Determination of proteins in urine, in 
subjects exposed to cadmium, has proven to be a 
good approach to protecting the population from 
potential health risks of exposure to toxic effects of 
cadmium (15). 
  Studies of people living in an area 
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have shown the presence of urinary excretion of 
protein markers: albumin, β2-microglobulin, retinol 
binding protein above 2 mg/g creatinine (16,20). 
  The kidney has an effective mechanisms that 
can compensate for some toxic effects. One example 
is the compensatory mechanisms of metallothionein in 
cadmium poisoning. Recovery after toxic renal 
damage may contribute to the regeneration of tissue 
in which the intact cells in close proximity differentiate 
and take proliferous function of damaged tissue. In 
this case, increased DNA synthesis in the kidneys is 
observed, promoted by many growth factors arriving 
to the injury spot through kidneys and circulation (1). 
 
  Toxic effects on the respiratory system 
 
  Cadmium-induced obstructive lung disease in 
humans can be slow at first, it results in chronic 
bronchitis, progressive fibrosis of the lower airways, 
and alveolar damage which leads to emphysema. 
Dyspnea, decreased vital capacity and increased 
residual volume have also been reported. Cadmium-
induced oxidative stress seems to play a major role in 
realizing the negative effects of cadmium in the lungs, 
which is associated with an increased risk of asthma 
(21) and pulmonary fibrosis (22). In vitro studies of 
lung cells have shown that cadmium induces 
apoptosis through a non-specific dependent 
mechanism, which is associated with the release 
of apoptotic factors from mitochondrial depolarization 
that accompanies mitochondrial membrane and 
transport apoptosis factors in the nucleus (23). 
 
  Effects on the skeletal system 
 
  Cadmium affects the metabolism of calcium 
and renal dysfunction by increasing the excretion of 
calcium, which appears in the urine. Skeletal changes 
are probably associated with the loss of calcium in 
parathyroid hormone and vitamin D. Cadmium can 
directly affect bone by stimulating osteoclast activity 
leading to the destruction of bone matrix. Exposure to 
cadmium causes renal dysfunction that is associated 
with hypercalciuria, nephrocalcinosis, osteoporosis 
and osteomalacia. Cadmium-contaminated rice 
causes Itai-Itai disease, which occurs mainly in older 
women and is characterized by serious osteomalacia 
and osteoporosis. This results in bone deformities and 
accompanying renal dysfunction. The lack of vitamin 
D, as well as some associated nutrients, may be a 
cofactor in the development of Itai-Itai disease. Data 
on bone loss, weight loss and frequent bone fractures 
were detected in populations exposed to much lower 
concentrations of cadmium, known as victims of Itai-
Itai disease (24). 
 
  Effects on the cardiovascular system 
 
  Vascular toxic effects of heavy metals such as 
cadmium, copper, zinc, selenium, lead, mercury are 
formed after the reaction with sulfhydryl, carboxyl and 
phosphate groups, although some of them can block 
the calcium channels. Although cadmium accumulates 
in the blood vessels less than in other tissues, its 
presence has been shown in large arteries (1). 
    Cadmium is localized in the elastic lamina of 
large arteries. Calcium has an antagonistic effect on 
cadmium-induced high blood pressure. Cadmium 
increases retention of salt, induces vasoconstriction 
and increased cardiac volume. Studies have shown 
that the vascular system and vascular endothelium 
are the target of cadmium toxicity (17). Cadmium 
cardiotoxicity is manifested in the form of reduced 
heart contractility, conductivity, due to structural 
changes in the myocardium (1). 
  Cadmium may be an etiological factor for 
cardiovascular diseases, including hypertension (1). 
 
  Neurotoxicity 
 
  Studies in humans suggest a link between 
abnormal behavior and / or reduced IQ in children 
and adults exposed to cadmium. Blood-brain barrier is 
permeable to cadmium. Direct toxic effects occur only 
when allowed to pass cadmium through the blood-
brain barrier, most often in young children or the 
dysfunction blood-brain barriers in certain pathological 
conditions. Choroid plexus epithelium can accumulate 
high levels of cadmium in reducing the level of other 
parts of the body (25). 
 
  Hepatotoxicity 
  
  The liver is the major site of metabolism and 
body for storage of cadmium in vivo. It produces 
metallothionein, which is then released into the 
circulation and further transported to the kidneys as 
well as to other target organs (15). The liver has a 
large capacity, reserves and the ability to induce 
antioxidant systems. There is a direct relationship 
between the levels of cadmium in urine and 
circulating levels of many antioxidant biomarkers in 
the blood. Circulating levels of these substances as 
markers of antioxidant liver are controlled. Chronic 
exposure of animals to cadmium increases glutathione 
transferase in the liver, which in turn leads to 
increased lipid peroxidation in the liver. Oxidative 
stress is a major reason for the emergence of 
hepatotoxicity (33). Thus, there might be an indirect 
connection between the liver and oxidative effects of 
cadmium in the body. Some of these parameters may 
i n  f u t u r e  b e  u s e d  a s  b i o m a r k e r s  o f  h e p a t o t o x i c i t y  
(26). 
  Tolerance to cadmium-induced acute hepato-
toxicity depends on synthesis of MT in the liver which 
stops the spread of cadmium and cytosol even with 
simultaneous reduction of the amount of cadmium 
capable of destroying other organelles (27). 
 
  Effects on the immune system 
  
  Exposure to cadmium has been shown to 
interfere with the normal function of immune 
cells. When given oraly to mice, cadmium 
increases susceptibility to herpes simplex virus 
type 2, decreases the production of T and B cells, 
but increases macrophage phagocytosis. In children 
of school age who are exposed to cadmium, a Toxic effects of cadmium                                                                                                                                  Tanja Vukićević 
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decrease of sensitivity and IgG antibody titers has 
been revealed. As is the case with many other 
immunotoxic substances, it is assumed that stress is 
responsible for the induction of apoptosis. Also, 
cadmium affects the production of cytokines (19). 
 
  Effects on the reproductive system 
 
  Cadmium in late pregnancy reduces blood flow 
to the placenta and inhibits the transport of nutrients 
through the placenta. Cadmium exposure of pregnant 
women leads to birth of children with lower body 
weight and increased incidence of spontaneous 
abortion. Cadmium accumulates in the ovaries over 
time, which is associated with reduced development 
of oocytes. Also, cadmium accumulates in the embryo 
(28). Low doses of cadmium stimulate ovarian 
progesterone synthesis, whereas higher doses inhibit 
it. Cadmium can cause changes in the production of 
sperm as well as other toxic effects on the 
reproductive function (1). 
  The testicles are the main target in the course 
of acute poisoning caused by cadmium. The effect is 
rapid. The testicles are first shriveled, which then 
follows the inflammation, edema, and severe 
hemorrhage and necrosis that occur in less than 
24 hours after the application of a single dose of 
cadmium (29). 
 
  Effects in the pediatric population 
 
  Children are particularly exposed to this metal. 
Children have a larger intake of food than adults 
relative to their weight, so the intake of cadmium to 
the body is larger in proportion. It is believed that 
children in the first months of life absorb from the 
digestive tract much more cadmium than adults. Low 
content of calcium, iron and protein, which are 
commonly found in the diet of children, can increase 
the absorption of cadmium. 
  Children who are exposed to adult smokers are 
at risk because they inhale the same amount of air as 
the people of middle age and their bodies bring in 
relatively more toxic metals (18,30). 
  
 Treatment 
  
  If the patient was exposed to cadmium, the 
following tests are proposed: 
1. The increased concentration of cadmium in 
blood, urine and hair  
2. General urine examination (proteinuria, 
glycosuria, amino-aciduria). 
3. Increased concentrations of calcium and 
phosphate in the urine. 
4. The five-day test mobilization chelates 
(CaNa2EDTA) is used to estimate the size 
of the depot 
5. Rtg pelvis and lungs 
6. Prostate exam after the age of forty is 
required. 
  Qualitative tests, for example, a test with 
sulphosalicylic acid or trichloroacetic acid reveals early 
tubular proteinuria, but can be used with advanced 
proteinuria, with the necessary of determination of 
β2-microglobulin in urine. 
  Determination of cadmium in blood and urine 
can be helpful in making the diagnosis (31). 
  During long-term exposure to cadmium, the 
cadmium concentration in urine higher than 10 µg/g 
creatinine indicates the existing or impending renal 
tubular damage. Concentrations of cadmium levels 
above 10µg/l (0.08µmol/l) indicate a significant 
exposure to cadmium (32). 
  There is no information that chelation therapy 
in acute poisoning is efficient. In case of poisoning by 
inhalation, blood tests are performed and the patient's 
condition is monitored. The exposed person is 
removed from further exposure to cadmium smoke 
and given oxygen if needed. In case of ingestion, loss 
of fluid is compensated and gastric lavage performed, 
but it does not cause vomiting because of cadmium 
salts irritants. Use of active charcoal is recommended 
(not given in case of diarrhea) (27). 
  Poisoning caused by cadmium inhalation is 
treated with respiratory insufficiency reanimation and 
pulmonary edema treatment. 
  Symptoms of chronic poisoning are due to final 
degenerative changes and cannot be repaired by 
chelators. Treatment of intoxication is conducted by 
administering chelators that bind cadmium, but the 
complex can cause nephrotoxic effects. However, the 
most effective is intravenous infusion of EDTA 
(ethylenediaminetetraacetic acid). Dimercaprol is not 
effective (1). 
  In kidney and liver damage, a symptomatic 
therapy is applied.  
  This is a correction of fluid and electrolyte 
imbalance. 
  People with acute poisoning do not suffer 
consequences for health in most cases. 
  More serious forms of acute and chronic 
poisoning can leave effects on the lungs, kidneys and 
liver, which can leave lasting effects on health, 
depending on the severity of organs. 
  People with professional cadmium poisoning 
lose their ability to work with cadmium and its 
compounds (34). 
 
 Conclusion 
 
  Many studies have shown that there is a direct 
correlation between exposure to the toxic effects of 
cadmium with renal impairment. In case of kidney 
damage, proteinuria is the most important indicator of 
the nephrotoxicity of cadmium. 
  Cadmium exerts its toxic effects on many other 
tissues and organs. Acute effects of cadmium on the 
body do not have permanent effects in contrast to the 
chronic effects in the case of which  some changes at 
the cellular level occur. 
  Owing to the advances in molecular biology, 
toxic effects of cadmium have been elucidated. 
However, the mechanism of carcinogenesis caused by 
cadmium remains unknown. 
  Protective role of metallothionein has been 
proven, not only in the acute and chronic toxicity of 
cadmium, but also in cadmium-induced carcino-
genesis with the exception of testicular damage. Its 
detoxifying role is primarily in the high binding affinity 
of the metals for metallothionein. 
  Preventing exposure to tobacco smoke as well 
as a proper diet which is rich in protein may be an 
important factor in preventing the toxic effects of 
cadmium exposure. Acta Medica Medianae 2012, Vol.51(4)                                                                                                 Toxic effects of cadmium 
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TOKSIČNI EFEKTI KADMIJUMA 
 
Tanja Vukićević 
 
 
Kadmijum spada u teške metale, često se koristi u industriji i ispoljava toksične 
efekte na ljudsko zdravlje. Kadmijum je klasifikovan kao kancerogena supstanca od 
strane International Agency for Research on Cancer  i spada u I grupu karcinogena. 
Kadmijum utiče na ciklus razvoja ćelije, proliferaciju, diferencijaciju, DNK reparaciju, 
replikaciju i apoptozu, kao i na promociju kancera u tkivima. Intoksikacija ljudi kadmi-
jumom najčešće se dešava inhalacijom dima cigareta, ali je moguća i putem vode, 
hrane i vazduha. Kadmijum ispoljava toksične efekte na bubrege, jetru, pluća, kardio-
vaskularni sistem, imunološki sistem i reproduktivni sistem. Glavni put kadmijuma u 
telu je vezivanje za metalotionein, protein male molekulske težine koji učestvuje u 
homeostazi nekih metala. Kompleks kadmijum-metalotionein se raspodeljuje u 
različitim tkivima. Uloga metalotioneina u detoksikaciji kadmijuma je prevashodno u 
velikom afinitetu vezivanja metala za metalotionein. Acta Medica Medianae 2012; 
51(4):65-70. 
 
Ključne reči: kadmijum, toksični efekti, karcinogena supstanca, metalotionein 